{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:52:52Z","timestamp":1764049972839,"version":"3.45.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Skull-base plasmacytoma (SBP) is a rare plasma cell neoplasm that typically presents as a slow-growing skull-base lesion in older adults; however, its molecular underpinnings are poorly characterized, limiting targeted therapeutic interventions and precise prognostication. We describe the case of a 67-year-old female who presented with progressive headaches, whose imaging and biopsy confirmed a solitary SBP with no evidence of systemic disease. Whole-exome sequencing revealed an elevated somatic copy number alteration burden and pathogenic variants in\n                    <jats:italic>ARID1A<\/jats:italic>\n                    ,\n                    <jats:italic>KMT2D<\/jats:italic>\n                    ,\n                    <jats:italic>BCL7A<\/jats:italic>\n                    ,\n                    <jats:italic>PTPN11<\/jats:italic>\n                    , and\n                    <jats:italic>NUP214<\/jats:italic>\n                    , suggesting disruptions in chromatin remodeling, B-cell neoplasm pathogenesis, and oncogenic signaling driving the tumorigenesis. These findings provide novel insights into molecular landscape of SBP, highlighting potential for risk stratification and targeted therapy development. The case underscores the importance of comprehensive genomic profiling in rare skull-based tumors to enhance our understanding of their biology and to guide personalized clinical management.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2025.1645502","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:11:47Z","timestamp":1764047507000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Genomic characterization of a rare skull-base plasmacytoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Hasan","family":"Alanya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreekar","family":"Kasturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanat","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batur","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Samper","family":"Figuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketu","family":"Mishra-Gorur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Gunel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Zeynep","family":"Erson-Omay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Bulent","family":"Omay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-002-0015-2","article-title":"Solitary bone plasmacytoma and extramedullary plasmacytoma","volume":"3","author":"Dimopoulos","year":"2002","journal-title":"Curr Treat Options Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"864058","DOI":"10.1155\/2014\/864058","article-title":"The genetic architecture of multiple myeloma","volume":"2014","author":"Prideaux","year":"2014","journal-title":"Adv Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-243535","article-title":"Classical and\/or alternative NF-kappaB pathway activation in multiple myeloma","volume":"115","author":"Demchenko","year":"2010","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1353943","article-title":"Case report: An uncommon presentation of extramedullary plasmacytoma without a concurrent diagnosis of multiple myeloma","volume":"14","author":"Stawarz","year":"2024","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma","volume":"5","author":"Bolli","year":"2014","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1560047","article-title":"Plasmacytoma of the skull base: A meta-analysis","volume":"77","author":"Na\u2019ara","year":"2016","journal-title":"J Neurol Surg B Skull Base"},{"key":"B10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2407-6-118","article-title":"Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","volume":"6","author":"Knobel","year":"2006","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00186-2","article-title":"Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy","volume":"41","author":"Liebross","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03353-5","article-title":"Multiple myeloma with high-risk cytogenetics and its treatment approach","volume":"115","author":"Hanamura","year":"2022","journal-title":"Int J Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0921-y","article-title":"Genome instability in multiple myeloma","volume":"34","author":"Neuse","year":"2020","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"key":"B15","article-title":"Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment","volume":"11","author":"Minguela","year":"2021","journal-title":"Am J Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1303.3997","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"B19","first-page":"467","volume-title":"Genomics in the cloud: using Docker, GATK, and WDL in Terra","author":"Van der Auwera","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13059-016-0973-5","article-title":"Vcfanno: fast, flexible annotation of genetic variants","volume":"17","author":"Pedersen","year":"2016","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks539","article-title":"SIFT web server: predicting effects of amino acid substitutions on proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat Protoc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Gene Ontology Consortium. Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-023-01336-1","article-title":"Sporadic pituitary adenoma with somatic double-hit loss of MEN1","volume":"26","author":"Hong","year":"2023","journal-title":"Pituitary"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16057","article-title":"Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer","volume":"115","author":"Sun","year":"2024","journal-title":"Cancer Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2024.01.012","article-title":"Glucocorticoid receptor signaling: intricacies and therapeutic opportunities","volume":"49","author":"Clarisse","year":"2024","journal-title":"Trends Biochem Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"107581","DOI":"10.1016\/j.jbc.2024.107581","article-title":"The histone methyltransferase KMT2D maintains cellular glucocorticoid responsiveness by shielding the glucocorticoid receptor from degradation","volume":"300","author":"Wu","year":"2024","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"215587","DOI":"10.1016\/j.canlet.2022.215587","article-title":"ARID1A loss-of-function induces CpG island methylator phenotype","volume":"532","author":"Yamada","year":"2022","journal-title":"Cancer Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blade","year":"2022","journal-title":"Blood Cancer J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/curroncol32030182","article-title":"Extramedullary multiple myeloma: challenges and opportunities","volume":"32","author":"Ho","year":"2025","journal-title":"Curr Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026588","article-title":"Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma","volume":"146","author":"Chakraborty","year":"2025","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-023-01736-8","article-title":"SWI\/SNF complexes in hematological Malignancies: biological implications and therapeutic opportunities","volume":"22","author":"Andrades","year":"2023","journal-title":"Mol Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00018-023-05052-8","article-title":"SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities","volume":"81","author":"Liu","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41408-024-01208-2","article-title":"Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma","volume":"15","author":"Bingham","year":"2025","journal-title":"Blood Cancer J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1068110","article-title":"Atypical ATMs: Broadening the phenotypic spectrum of ATM-associated hereditary cancer","volume":"13","author":"Borja","year":"2023","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1086\/302746","article-title":"ATM-heterozygous germline mutations contribute to breast cancer-susceptibility","volume":"66","author":"Broeks","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.3390\/cancers15164155","article-title":"Understanding DNA damage response and DNA repair in multiple myeloma","volume":"15","author":"Petrilla","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"13837","DOI":"10.1038\/ncomms13837","article-title":"ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A","volume":"7","author":"Williamson","year":"2016","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27988","article-title":"Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors","volume":"12","author":"Dhar","year":"2021","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1340726","article-title":"Tyrosine phosphatase PTPN11\/SHP2 in solid tumors - bull\u2019s eye for targeted therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0049-T","article-title":"Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated Malignancies","volume":"12","author":"Yu","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM mutations in cancer: therapeutic implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S372534","article-title":"A durable response of primary advanced colonic plasmacytoma using a combination of surgical resection and adjuvant bortezomib: A case report and literature review","volume":"15","author":"Alfar","year":"2022","journal-title":"Onco Targets Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408922","article-title":"Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA\/GEM study","volume":"120","author":"Rosinol","year":"2012","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.lrr.2024.100460","article-title":"Extramedullary plasmacytoma of the orbit complicating the evolution of multiple myeloma in complete remission","volume":"21","author":"Slama","year":"2024","journal-title":"Leuk Res Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1645502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:11:48Z","timestamp":1764047508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1645502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":56,"alternative-id":["10.3389\/fonc.2025.1645502"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1645502","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"1645502"}}